期刊文献+

2010年医院感染主要革兰阴性杆菌的分布及耐药性特点 被引量:6

Distribution and resistance of gram-negative bacilli induced nosocomial infections in 2010
原文传递
导出
摘要 目的探讨从医院感染患者中分离的革兰阴性杆菌分布及耐药性,为治疗医院感染患者提供依据。方法收集2010年285例住院患者医院感染革兰阴性杆菌的相关资料进行回顾性分析。结果共检出革兰阴性杆菌305株,主要为铜绿假单胞菌、大肠埃希菌、肺炎克雷伯菌、鲍氏不动杆菌、嗜麦芽寡养单胞菌和阴沟肠杆菌;肠杆菌科细菌对亚胺培南和美罗培南的耐药率为1.4%和2.0%;铜绿假单胞菌对亚胺培南、美罗培南的耐药率为34.0%、32.1%;鲍氏不动杆菌对亚胺培南、美罗培南的耐药率为28.9%和31.1%。结论亚胺培南和美罗培南对肠杆菌科仍保持高活性,但鲍氏不动杆菌、铜绿假单胞菌的耐药性已增加,应予以重视。 OBJECTIVE To investigate the species,distribution and resistance of gram-negative bacilli causing nosocomial infections,so as to guide management.METHODS The related data of 285 patients with nosocomial infections in 2010 were retrospectively analyzed.RESULTS A total of 305 gram-negative bacilli were isolated,the most common pathogens were Pseudomonas aeruginosa,Escherichia coli,Klebsiella pneumoniae,Acinetobacter baumannii,Stenotrophomonas maltophilia,and Enterobacter cloacae.The drug resistant rates of Enterobacteriaceae against imipenem and meropenem were 1.4% and 2.0% respectively.The drug resistant rates of P.aeruginosa against imipenem and meropenem were 34.0% and 32.1%,respectively.The drug resistant rates of A.baumannii against imipenem and meropenem were 28.9% and 31.1%.CONCLUSION Imipenem and meropenem remain highly active against Enterobacteriaceae,while the drug resistant rates of both A.baumannii and P.aeruginosa have increased,and which should be paid attention to.
作者 陈如昌
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2012年第6期1262-1264,共3页 Chinese Journal of Nosocomiology
关键词 医院感染 革兰阴性杆菌 药敏试验 耐药性 Nosocomial infection Gram-negative bacillus Drug susceptibility test Drug resisitance
  • 相关文献

参考文献4

二级参考文献52

共引文献276

同被引文献49

  • 1何磊.老年医学病房病原菌分布及耐药分析[J].医学检验与临床,2010(4):67-69. 被引量:2
  • 2唐冰,崔颖鹏,朱斌,朱家源,刘阳.外科非发酵菌感染的临床分布与耐药性分析[J].中华医院感染学杂志,2007,17(9):1147-1149. 被引量:12
  • 3Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimierobial susceptibility testing standards: nineteenth informational supplement[S]. 2009, MIO0-S19.
  • 4Dizbay M, Tunccan OG, Sezer BE, et al. Nosocomial imipenem-resistant acinetobacter baumannii infections: epidemiology and risk factors [J]. Scand J Infect Dis, 2010, 42 (10) : 741-746.
  • 5Kerr KG,Snelling AM. Pseudomonas aeruginosa: a formidable and ever-present adversary[J]. J Hosp Infect, 2009,73(4) : 338-344.
  • 6Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing,twentieth informational supplement[S].CLSI,2010.
  • 7Britt N S, Steed M E, Potter E M, et al. Tigecycline for the treatment of severe and severe complicated clostridium difficile infection [J]. Infectious Diseases & Therapy, 2014, 3(2): 321-331.
  • 8Kopterides P, Papageorgiou C, Antoniadou A, et al. Failure of tigecycline to treat severe Clostridium difficile infection [J]. Anaesth Intensive Care, 2010, 38(4): 755-758.
  • 9吴安华,李春辉.医院环境与住院患者耐甲氧西林金黄色葡萄球菌耐药性[J].中国医学科学院学报,2008,30(5):525-530. 被引量:14
  • 10黄佳玲,杨秀静.832株医院感染病原菌分布特点及耐药性分析[J].东南大学学报(医学版),2009,28(2):140-143. 被引量:6

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部